In one paragraphArticle in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors.
Yuki Kodama-MaruyamaDivision of Infections and Molecular Biology, Department of Advanced Pathophysiological Science, Kyushu Dental University, Kitakyushu 803-8580, Fukuoka, Japan.
Hiroki TsurushimaDivision of Oral Medicine, Department of Oral and Maxillofacial Disease Control, Kyushu Dental University, Kitakyushu 803-8580, Fukuoka, Japan.ORCID 0009-0000-9426-184X Ayaka KogaDivision of Infections and Molecular Biology, Department of Advanced Pathophysiological Science, Kyushu Dental University, Kitakyushu 803-8580, Fukuoka, Japan.ORCID 0009-0008-6259-6432 Yoshie Nagai-YoshiokaDivision of Infections and Molecular Biology, Department of Advanced Pathophysiological Science, Kyushu Dental University, Kitakyushu 803-8580, Fukuoka, Japan.ORCID 0009-0004-2615-6545 Ryota YamasakiDivision of Infections and Molecular Biology, Department of Advanced Pathophysiological Science, Kyushu Dental University, Kitakyushu 803-8580, Fukuoka, Japan.ORCID 0000-0003-1152-3248 Manabu HabuDivision of Oral and Maxillofacial Surgery, Department of Oral and Maxillofacial Disease Control, Kyushu Dental University, Kitakyushu 803-8580, Fukuoka, Japan.ORCID 0000-0002-6586-2539 Izumi YoshiokaDivision of Oral Medicine, Department of Oral and Maxillofacial Disease Control, Kyushu Dental University, Kitakyushu 803-8580, Fukuoka, Japan.
Wataru AriyoshiDivision of Infections and Molecular Biology, Department of Advanced Pathophysiological Science, Kyushu Dental University, Kitakyushu 803-8580, Fukuoka, Japan.ORCID 0000-0002-6533-5683 Funding
a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science 25K13154A Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science 23K21495The Yoshida Foundation for Academic and Educational Promotion 21H03145
6 · The paper itselfAbstract
Medication-related osteonecrosis of the jaw (MRONJ) is a refractory disease for which no established treatment currently exists. Surfactin, a biosurfactant produced by
Indexed as
LipopeptidesMacrophagesOsteonecrosisPeptides, CyclicAnimalsBiosurfactantsCell LineInterleukin-6LipopolysaccharidesMiceSignal TransductionTranscription Factor AP-1Interleukin-6LipopeptidesLipopolysaccharidesPeptides, Cyclicsurfactin peptideTranscription Factor AP-1AP-1IL-6JAK/STATMAPKMRONJsurfactin
Identifiers
PMID41683585
PMCPMC12897720
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390